Literature DB >> 2572817

Plasma mevalonate response in lovastatin-related myopathy.

V M Maher, A Pappu, D R Illingworth, G R Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2572817     DOI： 10.1016/s0140-6736(89)91109-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Rhabdomyolysis due to combined treatment with lovastatin and cholestyramine.

Authors:  C Chrysanthopoulos; N Kounis
Journal:  BMJ       Date:  1992-05-09

Review 2.  Clinical implications of new drugs for lowering plasma cholesterol concentrations.

Authors:  D R Illingworth
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.